# Pregnant Patient With Infrarenal Abdominal Aortic Aneurysm Successfully Treated With EVAR

**Authors:** Tomomi Ueda, Hiroki Yagi, Nana Akiyama, Naoya Akiba, Katsuyuki Hoshina, Hiroshi Akazawa, Norifumi Takeda, Norihiko Takeda

PMC · DOI: 10.1016/j.jaccas.2025.105287 · JACC Case Reports · 2025-10-01

## TL;DR

A pregnant woman with an abdominal aortic aneurysm successfully underwent a minimally invasive repair with careful radiation control.

## Contribution

Demonstrates successful EVAR during pregnancy with minimal fetal risk and emphasizes multidisciplinary care.

## Key findings

- EVAR can be safely performed during pregnancy with minimal radiation exposure.
- Multidisciplinary collaboration is essential for managing aortic aneurysms in pregnant patients.
- Genetic testing for hereditary aortopathy was negative in this case.

## Abstract

Pregnancy management in patients with a history of untreated aortic aneurysm or dissection is not established.

A patient with a chronic infrarenal abdominal aortic aneurysm and dissection was referred to our hospital at 13 weeks' gestation.

What are the treatment options for infrarenal abdominal aortic aneurysm with dissection in a pregnant patient? What tests are needed for treatment strategy? What are the safety considerations when performing endovascular aneurysm repair (EVAR) during pregnancy?

Genetic testing for established hereditary aortopathy genes was negative. After carvedilol treatment, EVAR was performed under ultrasound guidance with minimal radiation exposure at 19 weeks' gestation, allowing for adequate fetal growth. She had an uncomplicated vaginal delivery under epidural anesthesia at 39 weeks' gestation.

EVAR could be an effective treatment option during pregnancy if radiation exposure is properly minimized. Multidisciplinary collaboration, including early evaluation for connective tissue diseases, is essential to evaluate treatment strategy.

## Linked entities

- **Chemicals:** carvedilol (PubChem CID 2585)
- **Diseases:** abdominal aortic aneurysm (MONDO:0005350)

## Full-text entities

- **Diseases:** aneurysm (MESH:D000783), Abdominal Aortic Aneurysm (MESH:D017544), dissection (MESH:D000784), connective tissue diseases (MESH:D003240), aortic aneurysm (MESH:D001014), hereditary aortopathy (MESH:D009386)
- **Chemicals:** carvedilol (MESH:D000077261)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12540274/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12540274/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12540274/full.md

---
Source: https://tomesphere.com/paper/PMC12540274